ADP-dependent platelet function prior to and in the early course of pediatric Liver transplantation and persisting thrombocytopenia are positively correlated with ischemia/reperfusion injury

Transplant International

Volumn 23, Issue 7, 2010, Pages 745-752

  Schulte Am Esch II, Jan ^a   Akyildiz, Ayse ^b   Tustas, Roy Y ^a   Ganschow, Rainer ^b   Schmelzle, Moritz ^a   Krieg, Andreas ^a   Robson, Simon C ^c   Topp, Stefan A ^a   Rogiers, Xavier ^c   Knoefel, Wolfram T ^a   Fischer, Lutz ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Adenosine diphosphate; Liver transplantation; Pediatric; Platelet aggregation; Platelets; Thrombocytopenia

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; RISTOCETIN; VON WILLEBRAND FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT PERFUSION; GRAFT RECIPIENT; HUMAN; LIVER CELL DAMAGE; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIORITY JOURNAL; REPERFUSION INJURY; SERUM; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOTEST; ADOLESCENT; ADULT; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; PHYSIOLOGY;

ADENOSINE DIPHOSPHATE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET AGGREGATION; REPERFUSION INJURY; RISTOCETIN; THROMBOCYTOPENIA; VON WILLEBRAND FACTOR;

EID: 77953209845     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01054.x     Document Type: Article

References (32)

1. McCaughan GW, Herkes R, Powers B, et al. Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol 1992 16 : 16.
2. Chatzipetrou MA, Tsaroucha AK, Weppler D, et al. Thrombocytopenia after liver transplantation. Transplantation 1999 67 : 702.
3. Chang FY, Singh N, Gayowski T, et al. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 2000 69 : 70.
4. Moriga T, Arii S, Takeda Y, et al. Protection by vascular endothelial growth factor against sinusoidal endothelial damage and apoptosis induced by cold preservation. Transplantation 2000 69 : 141.
5. Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology 2000 118 : 183.
6. Cywes R, Packham MA, Tietze L, et al. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 1993 18 : 635.
7. Cywes R, Harvey PR, Packham MA, Cameron R, Strasberg SM. The influence of prostaglandin E1 on platelet adherence and injury in preserved rat liver allografts. Liver Transpl Surg 1996 2 : 23.
8. Ploeg RJ, AM DA, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993 55 : 807.
9. Piratvisuth T, Tredger JM, Hayllar KA, Williams R. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg 1995 1 : 296.
10. Doyle HR, Marino IR, Jabbour N, et al. Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?. Transplantation 1994 57 : 1028.
11. Schulte am Esch J II., Tustas RY, Robson SC, et al. Recipient levels and function of von Willebrand factor prior to liver transplantation and its consumption in the course of grafting correlate with hepatocellular damage and outcome. Transpl Int 2005 18 : 1258.
12. Sweeney JD, Hoernig LA, Fitzpatrick JE. Whole blood aggregation in von Willebrand disease. Am J Hematol 1989 32 : 190.
13. Russell-Smith NC, Flower RJ, Cardinal DC. Measuring platelet and leucocyte aggregation/adhesion responses in very small volumes of whole blood. J Pharmacol Methods 1981 6 : 315.
14. Ueda Y, Matsuo K, Kamei T, Kayashima K, Konomi K. Protective effect of prostaglandin E1 (PGE1) on energy metabolism and reticuloendothelial function in the ischemically damaged canine liver. Liver 1989 9 : 6.
15. Vukovic R, Simic M, Tasic M. [Analysis of ischemic lesions of the liver after various periods of warm and cold ischemia]. Med Pregl 1996 49 : 263.
16. Liu W, Schob O, Pugmire JE, et al. Glycohydrolases as markers of hepatic ischemia-reperfusion injury and recovery. Hepatology 1996 24 : 157.
17. Woodside KJ, Merion RM, Williams TC. Prospective multivariate analysis of donor monoethylglycine xylidide (MEGX) testing in liver transplantation. Transplantation Society of Michigan Scientific Studies Committee. Clin Transplant 1998 12 : 43.
18. Broering DC, Mueller L, Ganschow R, et al. Is there still a need for living-related liver transplantation in children? Ann Surg 2001 234 : 713.
19. Marino IR, Starzl TE, Aldrighetti L, et al. Risk factors and predictive indexes of early graft failure in liver transplantation. Ital J Gastroenterol 1996 28 : 163.
20. Ghobrial RM, Yersiz H, Farmer DG, et al. Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000 232 : 312.
21. Plevak DJ, Halma GA, Forstrom LA, et al. Thrombocytopenia after liver transplantation. Transplant Proc 1988 1 (Suppl 1 630.
22. Robson SC, Schulte am Esch J II., Bach FH. Factors in xenograft rejection. Ann N Y Acad Sci 1999 875 :
23. Schulte am Esch Jn, Rogiers X, Robson SC. Molecular incompatibilities in hemostasis between swine and men - impact on xenografting. Ann Transplant 2001 6 : 12.
24. Koyamada N, Miyatake T, Candinas D, et al. Apyrase administration prolongs discordant xenograft survival. Transplantation 1996 62 : 1739.
25. Nascimbene A, Iannacone M, Brando B, De Gasperi A. Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatment. J Hepatol 2007 47 : 651.
26. Owen CA Jr., Rettke SR, Bowie EJ, et al. Hemostatic evaluation of patients undergoing liver transplantation. Mayo Clin Proc 1987 62 : 761.
27. Bell R, Makin G, Robbins P, Robertson T, House AK. Hypothermic ischaemia of the liver: a re-perfusion phenomenon. ANZ J Surg 1997 67 : 442.
28. Suzumura N. [Coagulation disorders during orthotopic liver transplantation]. Nippon Geka Gakkai Zasshi 1989 90 : 847.
29. Wolber EM, Ganschow R, Burdelski M, Jelkmann W. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. Hepatology 1999 29 : 1739.
30. Bourdeaux C, Brunati A, Janssen M, et al. Liver retransplantation in children. A 21-year single-center experience. Transpl Int 2009 22 : 416.
31. Kawano Y, Mizuta K, Sugawara Y, et al. Diagnosis and treatment of pediatric patients with late-onset portal vein stenosis after living donor liver transplantation. Transpl Int 2009 22 : 1151.
32. Himmelreich G, Hundt K, Neuhaus P, Bechstein WO, Roissant R, Riess H. Evidence that intraoperative prostaglandin E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation 1993 55 : 819.